Olanzapine-induced somnambulism [1]

American Journal of Psychiatry

Volumn 158, Issue 7, 2001, Pages 1158-

  Kolivakis, T T ^a   Margolese, H C ^a   Beauclair, L ^a   Chouinard, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LOXAPINE; OLANZAPINE; RISPERIDONE; SEROTONIN 2C RECEPTOR; VALPROIC ACID;

ADULT; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DOSE RESPONSE; DRUG MECHANISM; DRUG USE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SLEEP WALKING;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRENZEPINE; SCHIZOPHRENIA; SOMNAMBULISM;

EID: 0034930405     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.7.1158     Document Type: Letter

References (6)

1. Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment
2. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine
3. Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency
4. 2C receptors in vivo
5. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep
6. Effects of clozapine on sleep: A longitudinal study